HEALTH

PHILADELPHIA — "Talk to your cardiologist." That's the advice offered Friday by Wills Eye Institute, a hospital specializing in eye care,  following a JAMA article linking aspirin therapy to macular degeneration. 

BRIDGEWATER, N.J. — Sanofi announced today that Auvi-Q (epinephrine injection, USP) is now available in U.S. retail pharmacies nationwide with a prescription from a healthcare provider.

SCOTTSDALE, Ariz. — AirWare Labs Corp. on Monday announced it will expand its sales and promotional marketing efforts of the AIR Allergy product in addition to the Sleep/Snore product as part of its continued commitment to a national rollout.

PARAMUS, N.J. — Oceans Omega on Monday launched Omega Infusion, an omega-3 EPA/DHA enhanced water product with initial placement within Giant Food.

"Delivering heart healthy omega-3 fatty acids in enhanced water is something we've been developing for years," stated Volker Berl, chief technology officer Oceans Omega. "Our proprietary delivery system is transforming the beverage industry by including ingredients like Omega-3 EPA/DHA."

WASHINGTON — As many as 7-in-10 U.S. adults track a health indicator for themselves or for a loved one, according to a Pew Research Center study released Monday. 

NEW YORK — Johnson & Johnson is shopping its women's health unit, according to a report Friday in The Wall Street Journal, which suggested that the business no longer coincided with J&J's "growth priorities." 

The brands managed by the unit include intimacy health KY and women's personal care brands, o.b. tampons and Stayfree and Carefree pads. 

SILVER SPRING, Md. — The Food and Drug Administration has approved three new drugs for Type 2 diabetes made by Takeda, the agency said Friday.

The FDA announced the approval of Nesina (alogliptin), Kazano (alogliptin and metformin) and Oseni (alogliptin and pioglitazone) tablets.

Alogliptin is a new active ingredient, while metformin and pioglitazone are drugs already on the market.